Kenneth T. Jones

Insider Reports History

Location
Devon, PA
Signature
/s/ Albert P. Parker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth T. Jones:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zynerba Pharmaceuticals, Inc. Vice President, Corporate Controller and Interim Chief Financial Officer Common Stock 0 $1.33 10 Oct 2023 Direct
Zynerba Pharmaceuticals, Inc. Vice President, Corporate Controller and Interim Chief Financial Officer Stock Option (Right to Buy) 0 10 Oct 2023 Direct

Insider Reports Filed by Kenneth T. Jones

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000114036123047746-jones-kenneth-t-2023-10-10 Zynerba Pharmaceuticals, Inc. 10 Oct 2023 4 $0 4 Vice President, Corporate Controller and Interim Chief Financial Officer 11 Oct 2023, 10:17
/report/000106299323018019-jones-kenneth-t-2023-09-12 Zynerba Pharmaceuticals, Inc. 12 Sep 2023 2 -$3,321 4 Vice President, Corporate Controller and Interim Chief Financial Officer 14 Sep 2023, 16:13
/report/000106299323016508-jones-kenneth-t-2023-08-08 Zynerba Pharmaceuticals, Inc. 08 Aug 2023 0 $0 3 Officer 15 Aug 2023, 16:05